SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-24-000527
Filing Date
2024-07-02
Accepted
2024-07-02 17:20:16
Documents
1
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5156
  Complete submission text file 0000912282-24-000527.txt   6979
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AYTU BIOPHARMA, INC. 373 INVERNESS PARKWAY, SUITE 206 ENGLEWOOD CO 80112
Business Address
PYSZCZYMUKA GREG (Reporting) CIK: 0001952920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 241097094